Member Info for EmeraldCarrots

Know so that might explain there have been no RNS's for 8 weeks. More and more hospitals we be users and generating regular income. The sp drop is to do with the Doctors strike and funding worries I think. However if they can demonstrate increasing income, which seems certain, if they do need funding it should ne be a problem.

All IMHO.

Ish late December 2024. Around a 50% loss in 7 months! Ouch! Maybe the total silence for the last 8 weeks is to do with good news. With no news for 8 weeks who knows! I bet they regret it now. What did they expect? Everyone knows a AIM Plc needs regular newsflow to keep punters interested. All very odd. They obviously have news from the on-going numerous hospital set ups. Hmm????? Maybe they are in bid discussions.

All IMHO.

Ish late December 2024. Around a 50% loss in 7 months! Maybe the total simence for the last 8 weeks is to do with good news. With no news for 8 weeks who knows!

It has been proven in the lab by varius Companies/Universities now. So why in heavens name has no Company I know of set up a cancer drug trial to rubber stamp it? The situation cannot continue. It is disgraceful that no Company (yet) has financed this. Companies like Astrazeneca should be leading the way. I have complained to the UK Government.

All IMHO.

Information it's hardly surprising the sp has slipped back. They must have realised it would. Are they just confident or stupid? Hopefully the former. They obviously are busy. Lots of new Genedrive® MT-RNR1 ID installations to get up and running to get to the 14 hospital total. Also the Genedrive® CYP2C19-ID Kit acute Coronary Syndrome evaluation to be set up in Manchester, and the preliminaries for the nationwide Scottish rollout of the Genedrive® MT-RNR1 ID. That is busy for a small Plc.

All IMHO.

In the UK and has "Breakthrough device designation" from the FDA already. A unique machine to the USA market. For sale. Market cap only £8 million. £20 million as it would probably be yours! You could not make it up. Joke of a share price if ever there was one.

https://www.lse.co.uk/rns/GDR/breakthrough-device-designation-from-the-us-fda-2zclfstav7guqaq.html

You never know. FDA clearance for the Genedrive(R) MT-RNR1 ID Kit would be worth $ millions to an established USA medical equipment supplier. That is totally obvious. Could become standard equipment for all the neonatal wards in the entire USA.

That would be rather good. Just could happen!

Doing RNS's is time consuming. I bet the board have to agree the wording and then the LSE check the facts, as all RNS's are vetted. They can do non-RNS if they want of course. Also they want a positive response to any RNS and so that is more likely after no news resulting in the sp dropping in the several weeks before. Hopefully a positive RNS is on it's way. Where we are with the last 5 English hospitals rollout, the Scottish nationwide rollout and the 2 FDA applications would be a good start. Also any more like Brighton that paid for the machine from the local budget. I feel parents, doctors and nurses simply must want the Genedrive MT-RNR1 ID kit in ALL neonatal wards. Oh, let's not forget International orders. Follow on's from France, Austria, Greece, Saudi Arabia, Turkey, the Netherlands and Italy.

All IMHO.

Until the Scottish rollout money kicks in, and the 14 English Genedrive® MT-RNR1 ID are up and running that's not too bad. It's what, 5 or so weeks only from them starting to invoice for the Scottish Rollout. I'm holding until we have an RNS to say where we are. They must be planning the Scottish rollout NOW and planning/doing the last 5 English hospitals at the moment. This excludes anything about the Genedrive® CYP2C19 ID of course!

All IMHO.

Executioner

"Just tried a dummy run and tried selling 100 thousand shares and market makers are not interested. Just sums up this company nobody is interested and its products will soon be obsolete with new AI technology round the corner .".

==============================

Very funny. That is a lie. Why am I so sure? Because market makers are not allowed to refuse to buy you fool.

You should be banned from this site.

Maybe Angle will want a lump sum each time a suitable biomarker is found from the DNA analysis of the CTC's? There is something going on here. This could make the likes of Astrazeneca tens of millions of additional profit. Indeed, any company that sells a cancer drug that uses cancer biomarkers to target a persons cancer. The situation is beyond ridiculous!

All IMHO.

Cancer biomarkers found to about double. Fact. Cancer biomarkers are looked for and if found there are cancer drugs that can target them, and so the cancer. Also fact. However, Angle plc has as yet NOT been contracted to do dual analysis during a cancer drug trial. This does not compute. They even have an Illumina assay panel specifically for lung cancer dual analysis available as of a few months back. It does not seem to make any sense at all. The only logical explanation is no-one is willing to pay for it, which seems unlikely, or Angle Plc is attaching conditions to any contract that puts Companies off. I'm thinking Angle Plc want a deal with a big Pharma Plc so if they use dual analysis to find about double the amount of clients eligible for biomarker targeted treatment Angle get a slice of the payment for the drug.

All IMHO.

It makes a lot of sense to have two Genedrive® MT-RNR1 ID Kits per hospital. Maybe more at the biggest ones. One in reserve for rare occasions when two babies need testing in the same "golden hour". Also, what is one goes wrong? I think two per hospital is the minimum. They are very small oo no storage issues. There are a minimum of 16 hospitals using these machines and the neonatal wards are of course open 24 hrs a day, 7 days a week. Once the testing rollout is fully deployed in England (14 hospitals, 9 already up and running) including the other sites the total will be 21 hospitals. Obviously once the 15 Scottish ones are online it will total 36 Hospitals. If there are 2 machines per hospital it makes a massive difference.

All IMHO.

Interesting that £800,000 divided by 15 hospitals is £53,333.33p per hospital. Seems a lot? I wonder why it's so much. Do Genedrive charge for the initial installation and training to use the machine? Also how many machines per hospital? Lots of questions.

https://www.gov.scot/news/improving-health-through-innovation/

Terms of payment for the rollout should include upfront payments for the machines and consumables prior to actual installation. So likely that money will be invoiced in september for payment in October. 15 neonatal hospitals in Scotland.

https://www.gov.scot/news/improving-health-through-innovation/

"A programme to provide a genetic test for newborn babies will also receive £800,000 funding to determine if they have a genetic variation which puts them at risk of permanent hearing loss if they are treated with a common emergency antibiotic.".

"This programme will begin in October and be rolled out to all Territorial Boards within 18 months.".

So will a placing be necessary? Maybe not.

All IMHO.

In answer to your question I suggest you ask Andrew Newland and this fellow, Brett Swansiger.

Brett has been at Angle for over 2 years now as the Chief Commercial Officer.

He seems to still be there but some shareholders probably wonder why? That includes me.

https://angleplc.com/team/brett-swansiger/

The local pub always seems busy?

=================

Are u serious. The trade at 15:27:18 was almost certainly a sell. Why do you think the ask went down from 1.3p to 1.25p so it looks like a buy? The trade **happened** when the bid was 1.25p and the ask was 1.3p. Immediately after the bid wend down to 1.2p ask the ask 1.25p. So that was after. Opem your eyes and use your brain.

The Illumina connection is no secret. The Roche one is real too I believe. So dual analysis involves/needs DNA analysis and they both do that. The faster the better to get the result to the physician asap. Tube of blood analysis by parsortix takes about 2 hours. So if same day the DNA analysis needs to take less than about 5 hours. Could be same day dual analysis report from receipt of blood sample. Food for thought. Certainly next day looks easy. Let's hope WES Streeting thinks the same. He has been informed of all this.

All IMHO.